Epigenetics

Serbia will make a drug for SMA: It will be cheaper and more effective than Zolgensma

The development of a significantly cheaper and more effective drug to alleviate the symptoms of spinal muscular atrophy in infants is the goal of the SMAIPROTACs project, which is financed by the Science Fund of Serbia within the Prizma program.

NASA sent one identical twin brother to space for a year and studied how it changed him

Last March, NASA astronaut Scott Kelly returned to Earth after spending nearly one year in space. During his 340 days aboard the International Space Station, or ISS, scientists were also observing Scott’s identical twin brother, Mark Kelly, while he hung out on Earth.